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Measuring patient-reported outcomes (PROs/PROMs) in people with Achilles 
tendinopathy: How useful is the VISA-A? 
It is important for clinicians and researchers to measure outcomes. Patient-reported 
outcome measures (PROMs) are short questionnaires, which are self-reported and 
designed to capture a person’s perceptions of specified aspects of their health 
status.[1] Conceptually, PROMs can be viewed either as a ‘tool for evaluation’ or as 
a ‘mechanism for improvement’ suited to the many factors that characterise a 
person’s health status that cannot be observed, measured with a device, or analysed 
with even the most sophisticated imaging methods.[2] Such questionnaires are 
ideally suited to areas such as tendinopathy where disease impact does not 
correlate consistently with biomarkers.  
The Victorian Institute of Sport- Achilles (VISA-A) questionnaire is a widely-used 
PROM for Achilles tendinopathy and is available in seven different languages. The 
ability of the VISA-A to improve decision making is determined by its reliability, 
validity and responsiveness to change, as these are essential psychometric 
properties for any measure.[3,4] Here we critically review the evidence that exists for 
the VISA-A questionnaire.   
Development 
The severity of Achilles tendinopathy is the construct of interest for the VISA-A, with 
validity and reliability first being examined by Robinson et al.[5] Content validity is 
defined as the degree to which the content of the PROM is an adequate reflection of 
the construct to be measured.[1,3] Content validity for the VISA-A was established 
from a pre-existing version of the questionnaire, interviewing colleagues, informally 
interviewing patients about their symptoms, and using a focus group of clinicians and 
subject experts. The inclusion of patients in this process is limited. Because the 
focus is on patient reported outcome, patients should be considered experts when 
judging the relevance of the items for the patient population.[3] As such, the 
relevance and comprehensiveness of the items in the VISA-A for the target 
population require further investigation, with additional consideration given to reflect 
current understanding of the multidimensional nature of the condition.[6] 
Construct validity is the degree to which the scores of the PROM are consistent with 
predetermined hypotheses based on the assumption that the PROM validly 
measures the construct of interest.[1,3] The formulation and testing of such 
hypotheses are missing from the VISA-A development, and the potential for the 
VISA-A to be measuring more than one construct has been identified.[7] The 
physical activity section of the VISA-A weighs heavily in the overall scoring (40/100). 
Consequently, if a person with Achilles tendinopathy is functioning at a high level 
despite pain, the construct of the VISA-A may lead to the view that they are less 
affected. As high level function precedes pain, they may be simply ‘pushing on’. 
In addition to validity, reliability was also tested by Robinson et al,[5] but only in a 
sporting population; they used cases referred to a sports medicine clinic or awaiting 
surgery and controls representing active individuals from a University population or 
running club. Given that only 35% of the general population with Achilles 
tendinopathy may describe a relationship to sports activity,[8] the VISA-A lacks 
evidence of reliability not only in non-sporting populations, but also a heterogeneous 
sporting population. Robinson et al[5] suggest that the VISA-A only be used in 
homogenous populations, and recognise the limitations of its use in non-sporting 
populations; a non-active person’s symptoms may resolve, yet they might only score 
50/100.  
Responsiveness is the ability of a PROM to detect change over time in the construct 
to be measured, thus referring to the validity of a change score.[3] As with evaluating 
criterion validity, a PROM responsiveness is required to be tested against 
hypotheses.[3] Whilst a minimum clinically important difference for the VISA-A has 
been cautiously suggested to be 6.5 points,[9] test-retest reliability has only been 
established at one week.[5] Pre-determined hypotheses require testing at longer-
term follow up to ascertain responsiveness. Longer-term follow up needs to allow 
time for sufficient clinical improvement, but still be short enough to assume the 
patients would be able to recall whether any changes in their condition had 
occurred.[10]   
In summary, the VISA-A was published in 2001, and has now been widely used, 
offering easy comparison between treatments from various clinics and research 
studies. In absence of an alternative PROM, clinicians and researchers might 
continue to use the VISA-A, despite the limited extent of evidence concerning the 
clinimetric properties for this PROM. However, since 2001 both our understanding of 
the multidimensional nature of tendinopathy and PROMs have developed, and as 
such the VISA-A requires updating. This critical review has highlighted the need for 
future research into the construct and content validity and responsiveness of the 
VISA-A. To ensure methodological rigor, this should follow the COnsensus-based 
Standards for selection of health Measurement Instruments (COSMIN) 
recommendations for terminology and research agenda.[3]  
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